| FEBS Letters | |
| Design of a chimeric promoter induced by pro‐inflammatory mediators in articular chondrocytes | |
| Meynier de Salinelles, Véronique1  Berenbaum, Francis1  Olivier, Jean-Luc1  Massaad, Charbel1  Béréziat, Gilbert1  Salvat, Colette1  Jacques, Claire1  Raymondjean, Michel1  | |
| [1] UMR Physiologie et Physiopathologie, Université Pierre et Marie Curie, 7 quai Saint Bernard, 75252 Paris, Cedex 05, France | |
| 关键词: Type IIA secreted phospholipase A2; Peroxisome proliferator-activated receptor; Interleukin-1β; Transcription; Chondrocyte; sPLA2-IIA; type IIA secreted phospholipase A2; PPAR; peroxisome proliferator-activated receptor; IL-1β; interleukin-1β; PGJ2; 15-deoxy Δ12; 14 prostaglandin J2; NSAID; non-steroidal anti-inflammatory drug; DR1; direct repeat 1; | |
| DOI : 10.1016/S0014-5793(02)02645-5 | |
| 学科分类:生物化学/生物物理 | |
| 来源: John Wiley & Sons Ltd. | |
PDF
|
|
【 摘 要 】
We have designed a chimeric promoter that can be stimulated by various pro-inflammatory mediators and so drive the expression of therapeutic genes under inflammatory conditions. The promoter has two parts, the [−247/+20] fragment of the human type IIA secreted phospholipase A2 gene promoter, which is stimulated by the pro-inflammatory cytokine interleukin-1β (IL-1β), and a double peroxisome proliferator-activated receptor response element that is activated by some eicosanoids and by non-steroidal anti-inflammatory drugs (NSAIDs). Transfection experiments using rabbit articular chondrocytes in primary culture showed that this chimeric promoter produced a low basal activity and was induced by NSAIDs, WY-14643, IL-1β, and 15-deoxy Δ12,14 prostaglandin J2. The latter two compounds stimulated the promoter synergistically.
【 授权许可】
Unknown
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| RO201912020311768ZK.pdf | 276KB |
PDF